• Explore /
  • Poster
  • / Paclitaxel oral solution versus paclitaxel injection as second-line therapy in advanced gastric cancer: A randomized, open-label, non-inferiority phase 3 trial.

Paclitaxel oral solution versus paclitaxel injection as second-line therapy in advanced gastric cancer: A randomized, open-label, non-inferiority phase 3 trial.

Abstract Poster

Authors

null

Jin Li

Shanghai East Hospital, Tongji University, Shanghai, China

Jin Li , Mingzhu Huang , Ting Deng , Yuxian Bai , Tianshu Liu , Yueyin Pan , Junyan Yu , Hongming Pan , Huiting Xu , Jufeng Wang , Feng Ye , Junye Wang , Jinsheng Wu , Shundong Cang , Kehe Chen , Jun Zhang , Jingdong Zhang , Yang Ling , Yin Liu , Shukui Qin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

CTR20190050

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 4051)

DOI

10.1200/JCO.2024.42.16_suppl.4051

Abstract #

4051

Poster Bd #

31

Abstract Disclosures

Similar Posters

First Author: Kohei Shitara

First Author: Nikhil I. Khushalani

First Author: Han Chong Toh

First Author: Markus H. Moehler